Trial
NCT01813838
GFM-Acadesine: A Phase I-II Trial of Acadesine
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Groupe Francophone des Myelodysplasies
Collaborators
Advancell - Advanced In Vitro Cell Technologies, S.A.
Condition
SMD
Intervention
ACADESINE 140mg/kg/d
Why stopped
Renal toxicity
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-11-08